Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation
- 29 March 2004
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 23 (23) , 4041-4049
- https://doi.org/10.1038/sj.onc.1207557
Abstract
Maspin has been demonstrated to be a suppressor of invasion and cell motility in vitro, whereas in vivo analyses have reported that increased expression of maspin is associated with malignant behavior. The present study examined maspin expression in normal lung and non-small-cell lung cancers. Only proximal airway cells in the normal lung expressed maspin, and the expression was associated with decreased methylation. This association was also observed in non-small-cell lung cancers, but the expression was quite different among histologic subtypes; 20 of 21 squamous cell carcinomas showed intense, uniform expression, whereas the expression status varied among adenocarcinomas. Of the 119 adenocarcinomas, 60 were negative, 23 positive and 36 showed a heterogeneous expression pattern. The expression was inversely correlated with markers of peripheral airway cells. Taken together, the results suggest that maspin may be expressed in association with the proximal airway cell type. It is of note that the heterogeneous expression pattern of maspin is quite distinctive, showing geographic positivity in the individual tumors. Separate analysis of methylation status in positive and negative portions of individual tumors provided an instance of intratumor diversity associated with promoter DNA methylation.Keywords
This publication has 35 references indexed in Scilit:
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Mutant p53 and aberrant cytosine methylation cooperate to silence gene expressionOncogene, 2003
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Role for DNA methylation in the control of cell type–specific maspin expressionNature Genetics, 2002
- Expression of Thyroid Transcription Factor-1, Cytokeratin 7, and Cytokeratin 20 in Bronchioloalveolar Carcinomas: an Immunohistochemical Evaluation of 67 CasesLaboratory Investigation, 2002
- Topographical Distributions of Allelic Loss in Individual Non-Small-Cell Lung CancersThe American Journal of Pathology, 2000
- Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tractOncogene, 1997
- High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungsZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Role for DNA methylation in genomic imprintingNature, 1993
- Screening patients for heterozygous p53 mutations using a functional assay in yeastNature Genetics, 1993